Who is sponsoring RAISC-RUTI?

RAISC-RUTI is sponsored by Study Group for Urogenital Diseases, Italy.

What condition does RAISC-RUTI study?

RAISC-RUTI studies Recurrent Urinary Tract Infections.

What is the status of RAISC-RUTI?

RAISC-RUTI is currently UNKNOWN.

Last reviewed 2014-02-11 · How we verify

INTRAVESICAL ADMINISTRATION OF COMBINED HYALURONIC ACID (HA) AND CHONDROITIN SULPHATE (CS) vs. STANDARD OF CARE FOR THE TREATMENT OF RECURRENT URINARY TRACT INFECTIONS (RUTIs) (RAISC-RUTI)

NCT02016118 UNKNOWN

The purpose of this study is to assess the effectiveness and costs associated with the intravesical administration of combined hyaluronic acid (HA) and chondroitin sulphate (CS) compared to the current standard management of recurrent urinary tract infections in adult women diagnosed with recurrent urinary tract infections (RUTI).

Details

Lead sponsor	Study Group for Urogenital Diseases, Italy
Status	UNKNOWN
Enrolment	500
Start date	2014-01
Completion	2014-12

Conditions

Recurrent Urinary Tract Infections

Interventions

Ialuril

Primary outcomes

Occurrence of Urinary tract infection recurrence — within 12 months after treatment initiation
At least one bacteriologically confirmed urinary tract infection experienced within 12 months after the treatment initiation.

Countries

Italy